Propath is a leader in Europe for histopathology and molecular pathology. As a GLP and GCP compliant facility, our experience of regulatory and research studies spans over 30 years.
We provide expert, regulatory compliant services in histology, immunohistochemistry, in situ hybridisation, tissue cross-reactivity, pathology evaluation and whole slide digital scanning.
Our focus is on preclinical safety assessment of pharmaceuticals, therapeutic antibodies, chemicals and medical devices; and our strengths are in supporting regulatory toxicology studies and assessing on/off‐target binding and biodistribution of novel therapeutic antibodies.
We serve clients across the pharmaceutical and biopharmaceutical spectrum, chemical and agrochemical companies, contract research organisations, research institutes and government departments.
Our reputation has been gained by focusing relentlessly on the quality of our advice, the standard of our work and the responsiveness of our service.
For advice on your specific project or more information about our services, please feel free to contact us.